Denali Therapeutics prices $275M stock offering

Oct. 20, 2022 4:56 AM ETDenali Therapeutics Inc. (DNLI)By: Meghavi Singh, SA News Editor
  • Denali Therapeutics (NASDAQ:DNLI) has priced its underwritten public offering of 10,377,359 shares of its common stock at a price to the public of $26.50/share.
  • All of the shares are to be sold by Denali Therapeutics.
  • Underwriters are granted a 30-day option to purchase up to an additional 1,556,603 shares of its common stock.
  • Denali Therapeutics expects to receive total gross proceeds of ~$275M.
  • Offering is expected to close on or about October 24, 2022.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.